Nytricx Inc

Nytricx Inc., a spinoff from the University of Georgia in Athens, specializes in the development of nitric oxide-releasing anti-microbial medical devices, focusing on solutions that enhance healing and improve treatment outcomes. The company is committed to creating innovative and safe medical technologies that address complications in critical care settings.

Utilizing its proprietary NORel technology, Nytricx harnesses the pharmacological properties of nitric oxide, which plays a vital role in the body's innate immune system. This technology offers sustained activity without generating toxic byproducts, ensuring compatibility with cellular environments while reducing the risk of drug resistance.

Generated from the website